SIRP-NNP-ASO

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameSIRP-NNP-ASO
Drug Alias NameSIRP-NNP-ASO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsGene silencing
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShiftBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesShiftBio Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A